216 related articles for article (PubMed ID: 36725887)
1. Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growth.
Scott E; Hodgson K; Calle B; Turner H; Cheung K; Bermudez A; Marques FJG; Pye H; Yo EC; Islam K; Oo HZ; McClurg UL; Wilson L; Thomas H; Frame FM; Orozco-Moreno M; Bastian K; Arredondo HM; Roustan C; Gray MA; Kelly L; Tolson A; Mellor E; Hysenaj G; Goode EA; Garnham R; Duxfield A; Heavey S; Stopka-Farooqui U; Haider A; Freeman A; Singh S; Johnston EW; Punwani S; Knight B; McCullagh P; McGrath J; Crundwell M; Harries L; Bogdan D; Westaby D; Fowler G; Flohr P; Yuan W; Sharp A; de Bono J; Maitland NJ; Wisnovsky S; Bertozzi CR; Heer R; Guerrero RH; Daugaard M; Leivo J; Whitaker H; Pitteri S; Wang N; Elliott DJ; Schumann B; Munkley J
Oncogene; 2023 Mar; 42(12):926-937. PubMed ID: 36725887
[TBL] [Abstract][Full Text] [Related]
2. The role of GCNT1 mediated O-glycosylation in aggressive prostate cancer.
Hodgson K; Orozco-Moreno M; Scott E; Garnham R; Livermore K; Thomas H; Zhou Y; He J; Bermudez A; Garcia Marques FJ; Bastian K; Hysenaj G; Archer Goode E; Heer R; Pitteri S; Wang N; Elliott DJ; Munkley J
Sci Rep; 2023 Oct; 13(1):17031. PubMed ID: 37813880
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA-SNHG7 acts as a target of miR-34a to increase GALNT7 level and regulate PI3K/Akt/mTOR pathway in colorectal cancer progression.
Li Y; Zeng C; Hu J; Pan Y; Shan Y; Liu B; Jia L
J Hematol Oncol; 2018 Jul; 11(1):89. PubMed ID: 29970122
[TBL] [Abstract][Full Text] [Related]
4. Glycosylation is a global target for androgen control in prostate cancer cells.
Munkley J
Endocr Relat Cancer; 2017 Mar; 24(3):R49-R64. PubMed ID: 28159857
[TBL] [Abstract][Full Text] [Related]
5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of GCNT1 is associated with altered O-glycosylation of PSA, PAP, and MUC1 in human prostate cancers.
Chen Z; Gulzar ZG; St Hill CA; Walcheck B; Brooks JD
Prostate; 2014 Jul; 74(10):1059-67. PubMed ID: 24854630
[TBL] [Abstract][Full Text] [Related]
7. O-glycosylation regulates LNCaP prostate cancer cell susceptibility to apoptosis induced by galectin-1.
Valenzuela HF; Pace KE; Cabrera PV; White R; Porvari K; Kaija H; Vihko P; Baum LG
Cancer Res; 2007 Jul; 67(13):6155-62. PubMed ID: 17616672
[TBL] [Abstract][Full Text] [Related]
8. The role of glycans in the development and progression of prostate cancer.
Munkley J; Mills IG; Elliott DJ
Nat Rev Urol; 2016 Jun; 13(6):324-33. PubMed ID: 27091662
[TBL] [Abstract][Full Text] [Related]
9. Altered glycosylation in prostate cancer.
Drake RR; Jones EE; Powers TW; Nyalwidhe JO
Adv Cancer Res; 2015; 126():345-82. PubMed ID: 25727153
[TBL] [Abstract][Full Text] [Related]
10. Mass Spectrometry-Based Glycoproteomics and Prostate Cancer.
Gabriele C; Prestagiacomo LE; Cuda G; Gaspari M
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069262
[TBL] [Abstract][Full Text] [Related]
11. Aberrant PSA glycosylation--a sweet predictor of prostate cancer.
Gilgunn S; Conroy PJ; Saldova R; Rudd PM; O'Kennedy RJ
Nat Rev Urol; 2013 Feb; 10(2):99-107. PubMed ID: 23318363
[TBL] [Abstract][Full Text] [Related]
12. Metastatic Progression of Prostate Cancer Is Mediated by Autonomous Binding of Galectin-4-O-Glycan to Cancer Cells.
Tsai CH; Tzeng SF; Chao TK; Tsai CY; Yang YC; Lee MT; Hwang JJ; Chou YC; Tsai MH; Cha TL; Hsiao PW
Cancer Res; 2016 Oct; 76(19):5756-5767. PubMed ID: 27485450
[TBL] [Abstract][Full Text] [Related]
13. UAP1 is overexpressed in prostate cancer and is protective against inhibitors of N-linked glycosylation.
Itkonen HM; Engedal N; Babaie E; Luhr M; Guldvik IJ; Minner S; Hohloch J; Tsourlakis MC; Schlomm T; Mills IG
Oncogene; 2015 Jul; 34(28):3744-50. PubMed ID: 25241896
[TBL] [Abstract][Full Text] [Related]
14. ETS1 transcriptional activity is increased in advanced prostate cancer and promotes the castrate-resistant phenotype.
Smith AM; Findlay VJ; Bandurraga SG; Kistner-Griffin E; Spruill LS; Liu A; Golshayan AR; Turner DP
Carcinogenesis; 2012 Mar; 33(3):572-80. PubMed ID: 22232738
[TBL] [Abstract][Full Text] [Related]
15. Sialic acid blockade inhibits the metastatic spread of prostate cancer to bone.
Hodgson K; Orozco-Moreno M; Goode EA; Fisher M; Garnham R; Beatson R; Turner H; Livermore K; Zhou Y; Wilson L; Visser EA; Pijnenborg JF; Eerden N; Moons SJ; Rossing E; Hysenaj G; Krishna R; Peng Z; Nangkana KP; Schmidt EN; Duxfield A; Dennis EP; Heer R; Lawson MA; Macauley M; Elliott DJ; Büll C; Scott E; Boltje TJ; Drake RR; Wang N; Munkley J
EBioMedicine; 2024 May; 104():105163. PubMed ID: 38772281
[TBL] [Abstract][Full Text] [Related]
16. Human prostate cancer in a clinically relevant xenograft mouse model: identification of β(1,6)-branched oligosaccharides as a marker of tumor progression.
Lange T; Ullrich S; Müller I; Nentwich MF; Stübke K; Feldhaus S; Knies C; Hellwinkel OJ; Vessella RL; Abramjuk C; Anders M; Schröder-Schwarz J; Schlomm T; Huland H; Sauter G; Schumacher U
Clin Cancer Res; 2012 Mar; 18(5):1364-73. PubMed ID: 22261809
[TBL] [Abstract][Full Text] [Related]
17. O-glycosylated clusterin as a sensitive marker for diagnosing early stages of prostate cancer.
Kazuno S; Fujimura T; Fujime M; Miura Y; Ueno T
Prostate; 2021 Feb; 81(3):170-181. PubMed ID: 33347638
[TBL] [Abstract][Full Text] [Related]
18. Pharmacologic inhibition of Jak2-Stat5 signaling By Jak2 inhibitor AZD1480 potently suppresses growth of both primary and castrate-resistant prostate cancer.
Gu L; Liao Z; Hoang DT; Dagvadorj A; Gupta S; Blackmon S; Ellsworth E; Talati P; Leiby B; Zinda M; Lallas CD; Trabulsi EJ; McCue P; Gomella L; Huszar D; Nevalainen MT
Clin Cancer Res; 2013 Oct; 19(20):5658-74. PubMed ID: 23942095
[TBL] [Abstract][Full Text] [Related]
19. High OGT activity is essential for MYC-driven proliferation of prostate cancer cells.
Itkonen HM; Urbanucci A; Martin SE; Khan A; Mathelier A; Thiede B; Walker S; Mills IG
Theranostics; 2019; 9(8):2183-2197. PubMed ID: 31149037
[TBL] [Abstract][Full Text] [Related]
20. O-GlcNAc-glycosylation of beta-catenin regulates its nuclear localization and transcriptional activity.
Sayat R; Leber B; Grubac V; Wiltshire L; Persad S
Exp Cell Res; 2008 Sep; 314(15):2774-87. PubMed ID: 18586027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
